Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 66
Filter
1.
Nat Med ; 7(11): 1209-16, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11689885

ABSTRACT

Cyclic ADP-ribose is believed to be an important calcium-mobilizing second messenger in invertebrate, mammalian and plant cells. CD38, the best-characterized mammalian ADP-ribosyl cyclase, is postulated to be an important source of cyclic ADP-ribose in vivo. Using CD38-deficient mice, we demonstrate that the loss of CD38 renders mice susceptible to bacterial infections due to an inability of CD38-deficient neutrophils to directionally migrate to the site of infection. Furthermore, we show that cyclic ADP-ribose can directly induce intracellular Ca++ release in neutrophils and is required for sustained extracellular Ca++ influx in neutrophils that have been stimulated by the bacterial chemoattractant, formyl-methionyl-leucyl-phenylalanine (fMLP). Finally, we demonstrate that neutrophil chemotaxis to fMLP is dependent on Ca++ mobilization mediated by cyclic ADP-ribose. Thus, CD38 controls neutrophil chemotaxis to bacterial chemoattractants through its production of cyclic ADP-ribose, and acts as a critical regulator of inflammation and innate immune responses.


Subject(s)
Adenosine Diphosphate Ribose/analogs & derivatives , Adenosine Diphosphate Ribose/biosynthesis , Antigens, CD , Antigens, Differentiation/metabolism , Calcium Signaling/physiology , Chemotaxis, Leukocyte/physiology , NAD+ Nucleosidase/metabolism , NAD/analogs & derivatives , Neutrophils/physiology , ADP-ribosyl Cyclase , ADP-ribosyl Cyclase 1 , Animals , Antigens, Differentiation/genetics , Chemotaxis, Leukocyte/drug effects , Cyclic ADP-Ribose , Lymphoid Tissue/enzymology , Lymphoid Tissue/immunology , Membrane Glycoproteins , Mice , Mice, Inbred C57BL , Mice, Knockout , N-Formylmethionine Leucyl-Phenylalanine/pharmacology , NAD/pharmacology , NAD+ Nucleosidase/genetics , Neutrophils/drug effects , Neutrophils/immunology , Pneumococcal Infections/etiology , Ryanodine/pharmacology , Streptococcus pneumoniae/immunology
2.
J Photochem Photobiol B ; 63(1-3): 141-7, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11684461

ABSTRACT

Ionizing- and ultraviolet-radiation cause cell damage or death by directly altering DNA and protein structures and by production of reactive oxygen species (ROS) and reactive carbonyl species (RCS). These processes disrupt cellular energy metabolism at multiple levels. The formation of DNA strand breaks activates signaling pathways that consume NAD, which can lead to the depletion of cellular ATP. Poly(ADP)-ribose polymerase (PARP-1) is the enzyme responsible for much of the NAD degradation following DNA damage, although numerous other PARPs have been discovered recently that await functional characterization. Studies on mouse epidermis in vivo and on human cells in culture have shown that UV-B radiation provokes the transient degradation of NAD and the synthesis of ADP-ribose polymers by PARP-1. This enzyme functions as a component of a DNA damage surveillance network in eukaryotic cells to determine the fate of cells following genotoxic stress. Additionally, the activation of PARP-1 results in the activation of a nuclear proteasome that degrades damaged nuclear proteins including histones. Identifying approaches to optimize these responses while maintaining the energy status of cells is likely to be very important in minimizing the deleterious effects of solar radiation on skin.


Subject(s)
Energy Metabolism/radiation effects , Skin/radiation effects , Animals , Humans , NAD/metabolism , Poly(ADP-ribose) Polymerases/metabolism , Skin/cytology , Skin/immunology , Skin/metabolism , Solar Activity , Ultraviolet Rays/adverse effects
3.
J Cancer Res Clin Oncol ; 127(7): 425-32, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11469679

ABSTRACT

PURPOSE: To study in vitro the effect of carboplatin and/or hyperthermia in relation to etoposide (VP-16) cytotoxicity in L929 cells. METHODOLOGY/RESULTS: Cell survival assays demonstrated that the addition of 41.8 degrees C (x60 min) hyperthermia and carboplatin to VP-16 produced an antagonistic effect relative to VP-16 cytotoxicity in L929 cells; administering carboplatin and hyperthermia 24 h before VP-16 reduced this drug resistance; administering carboplatin and hyperthermia 48 h before VP-16, however, produced a supra-additive cytotoxicity. In order to gain insight into the molecular basis for these observations, we investigated the effect of hyperthermia and/or carboplatin on the stress protein GRP78, which is known to affect VP-16 cytotoxicity. Results obtained were consistent with the hypothesis that carboplatin and hyperthermia perturbation of NAD + pools results in down-regulation of GRP78 with subsequent modulation of VP-16 cytotoxicity. To further explicate these results we studied G-361 as a control cell line that had significantly higher pretreatment NAD+ levels, which were not affected by carboplatin and/or hyperthermia. This cell line did not exhibit a down-regulation of GRP78 or modulation of VP-16 cytotoxicity as a function of carboplatin and hyperthermia. CONCLUSIONS: These data taken collectively, demonstrate a sequence effect (regarding the aforementioned antineoplastic agents), and provide a framework for future studies directed at the therapeutic optimization of the sequential application of carboplatin, hyperthermia, and VP-16.


Subject(s)
Antineoplastic Agents, Phytogenic/antagonists & inhibitors , Antineoplastic Agents/pharmacology , Carboplatin/pharmacology , Etoposide/antagonists & inhibitors , Fibrosarcoma/drug therapy , Hyperthermia, Induced , Animals , Blotting, Western , Cell Survival/drug effects , Electrophoresis, Polyacrylamide Gel , Endoplasmic Reticulum Chaperone BiP , Fibrosarcoma/metabolism , Fibrosarcoma/pathology , Mice , NAD/metabolism , Time Factors , Tumor Cells, Cultured
4.
Biochem J ; 351 Pt 3: 769-77, 2000 Nov 01.
Article in English | MEDLINE | ID: mdl-11042133

ABSTRACT

Non-enzymic damage to nuclear proteins has potentially severe consequences for the maintenance of genomic integrity. Introduction of carbonyl groups into histones in vivo and in vitro was assessed by Western blot immunoassay and reductive incorporation of tritium from radiolabelled NaBH(4) (sodium borohydride). Histone H1 extracted from bovine thymus, liver and spleen was found to contain significantly elevated amounts of protein-bound carbonyl groups as compared with core histones. The carbonyl content of nuclear proteins of rat pheochromocytoma cells (PC12 cells) was not greatly increased following oxidative stress induced by H(2)O(2), but was significantly increased following alkylating stress induced by N-methyl-N'-nitro-N-nitrosoguanidine or by combined oxidative and alkylating stress. Free ADP-ribose, a reducing sugar generated in the nucleus in proportion to DNA strand breaks, was shown to be a potent histone H1 carbonylating agent in isolated PC12 cell nuclei. Studies of the mechanism of histone H1 modification by ADP-ribose indicate that carbonylation involves formation of a stable acyclic ketoamine. Our results demonstrate preferential histone H1 carbonylation in vivo, with potentially important consequences for chromatin structure and function.


Subject(s)
Histones/metabolism , Ketones/metabolism , Adenosine Diphosphate Ribose/metabolism , Animals , Cattle , Electrophoresis, Polyacrylamide Gel , Glucose/metabolism , Ketones/chemistry , Molecular Structure , Oxidation-Reduction , PC12 Cells , Rats
5.
HIV Clin Trials ; 1(3): 1-15, 2000.
Article in English | MEDLINE | ID: mdl-11590500

ABSTRACT

PURPOSE: Previous studies with intermittent interleukin-2 (IL-2) therapy using intermediate and high levels of IL-2 have demonstrated significant increases in the CD4 + T cell count in HIV-infected patients. Intermittent regimens are amenable to outpatient use, but severe adverse events are frequently experienced with intermediate- and high-dose levels of IL-2. Therefore in this study, the effect of daily, subcutaneous low-dose IL-2 therapy on safety and immunological endpoints was investigated to determine whether immunological benefit could be achieved without toxicity in HIV-infected patients also receiving highly active antiretroviral therapy (HAART). METHOD: A total of 115 patients were enrolled in the trial. Fifty-six asymptomatic HIV-infected patients who had CD4 + T cell counts less than 300 cells/microL at screening and a stable HIV viral load received low-dose IL-2 (1.2 million IU [MIU]/m 2 beginning dose) once daily in conjunction with HAART (IL-2 group). Fifty-nine patients received HAART alone (control group). RESULTS: A dramatic effect of IL-2 on the natural killer (NK) cell population was observed with mean increases of 156 cells/microL in the IL-2 group compared to 19.93 cells/microL in the control group (p <.001). Additionally, IL-2-treated patients experienced a statistically significant increase in the mean percentage of CD4 + T cells (3.52% increase) when compared to control patients (1.33% increase) (p <.001). The expanded CD4 + T cell population was primarily of the naive phenotype, with mean increases of 4.53% for the IL-2 group and 0.31% for the control group (p <.001 for between-group difference). In addition, a higher proportion of IL-2-treated patients (67%) compared to control patients (33%) achieved increases of greater than 50% in the CD4+ T cell count (p =.08). Adverse events of grade 3 or grade 4 toxicity were infrequent in the current study and were substantially lower by comparison to those in studies of intermittent dose IL-2 therapy. Also, negligible changes in the HIV viral load from baseline to final measurement were observed in both groups. A trend toward a reduced number of modifications of antiretroviral therapy was apparent in the IL-2 group when compared to control patients. CONCLUSION: Daily, low-dose subcutaneous IL-2 therapy in conjunction with HAART is safe and well tolerated and is effective in expanding lymphocyte cell types including NK cells and naive T cells in individuals who have <300 CD4+ T cells.


Subject(s)
Antiretroviral Therapy, Highly Active , HIV Infections/drug therapy , HIV Infections/immunology , Interleukin-2/administration & dosage , Interleukin-2/adverse effects , Adult , CD4 Lymphocyte Count , Drug Therapy, Combination , Female , HIV Infections/virology , HIV-1/isolation & purification , HIV-1/physiology , Humans , Injections, Subcutaneous , Interleukin-2/therapeutic use , Male , Middle Aged , Viral Load
6.
HIV Clin Trials ; 1(3): 16-22, 2000.
Article in English | MEDLINE | ID: mdl-11590501

ABSTRACT

PURPOSE AND METHOD: Chronic infection with HIV renders individuals incapable of mounting an effective host antiviral response, as defined by in vitro assays. Therefore, to determine whether antiviral reactivity could be detected in vivo, we interrupted effective antiviral treatment prospectively in nine chronically infected aviremic individuals. Low-dose interleukin-2 (IL-2) was administered before and after treatment interruption to compensate for any potential IL-2 production deficiency. In vivo antiviral reactivity was monitored subsequent to the interruption of antiviral therapy via viral and lymphocyte dynamics. The study was terminated when the plasma HIV RNA concentration reached a plateau, defined as four successive determinations that were <25% from the mean. RESULTS: Plasma viral relapse occurred in all participants; reaching a peak concentration within 2.5 weeks. However, over the subsequent 2 weeks viremia was reduced an order of magnitude coincident with a 2-fold lymphocytosis of the CD8 + T cell subset. A second treatment interruption resulted in attenuation of the peak and trough virus concentrations by <10-fold in 3 of 4 participants, while the CD8 + T cell concentrations remained elevated. CONCLUSION: These findings indicate that chronic HIV infection prior to successful antiviral therapy does not preclude host antiviral reactivity. In addition, in vivo antiviral reactivity as revealed by viral and lymphocyte dynamics after antiviral treatment interruption can be useful to monitor the efficacy of different therapies.


Subject(s)
Antiretroviral Therapy, Highly Active , HIV Infections/drug therapy , HIV Infections/immunology , HIV-1/immunology , Interleukin-2/administration & dosage , CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , Chronic Disease , Drug Administration Schedule , Drug Therapy, Combination , HIV Infections/virology , HIV-1/physiology , Humans , Interleukin-2/immunology , Killer Cells, Natural , RNA, Viral/blood
9.
Nutr Cancer ; 34(1): 36-41, 1999.
Article in English | MEDLINE | ID: mdl-10453439

ABSTRACT

Topical nicotinamide (niacinamide) has demonstrable preventive activity against photocarcinogenesis in mice. To better understand how this vitamin prevents ultraviolet (UV) carcinogenesis, we tested systemic administration of another form of the vitamin, niacin, and its capacity to elevate cutaneous nicotinamide-adenine dinucleotide (NAD) content as well as to decrease photoimmunosuppression and photocarcinogenesis. BALB/cAnNTacfBR mice were fed the AIN-76A diet supplemented with 0%, 0.1%, 0.5%, or 1.0% niacin throughout the experiment. UV irradiation consisted of five 30-minute exposures per week to banks of six FS40 Westinghouse sunlamps for 22 weeks in the carcinogenesis experiments, yielding a total cumulative dose of approximately 1.41 x 10(6) Jm-2 of UV-B radiation. Dietary supplementation with 0.1%, 0.5%, or 1.0% niacin reduced the control incidence of skin cancer from 68% to 60%, 48%, and 28%, respectively, at 26.5 weeks after the first UV treatment. Two potential mechanisms by which niacin prevents tumor formation were identified. Photoimmunosuppression, critical for photocarcinogenesis, is measured by a passive transfer assay. Syngeneic, antigenic tumor challenges grew to an average of 91.6 +/- 19.7, 79.8 +/- 11.5, 41.9 +/- 11.7, or 13.2 +/- 4.1 mm2 in naive recipients of splenocytes from UV-irradiated mice treated with 0%, 0.1%, 0.5%, or 1.0% niacin supplementation, respectively, demonstrating niacin prevention of immunosuppression. Niacin supplementation elevated skin NAD content, which is known to modulate the function of DNA strand scission surveillance proteins p53 and poly(ADP-ribose) polymerase, two proteins critical in cellular responses to UV-induced DNA damage. These results clearly demonstrate a dose-dependent preventive effect of oral niacin on photocarcinogenesis and photoimmunosuppression and establish the capacity of oral niacin to elevate skin NAD levels.


Subject(s)
Anticarcinogenic Agents/therapeutic use , Immunosuppression Therapy , Neoplasms, Radiation-Induced/prevention & control , Niacin/therapeutic use , Skin Neoplasms/prevention & control , Administration, Oral , Animals , Anticarcinogenic Agents/administration & dosage , Antigens, Neoplasm/metabolism , Dietary Supplements , Dose-Response Relationship, Drug , Female , Immunization, Passive , Mice , Mice, Inbred BALB C , NAD/metabolism , Neoplasms, Radiation-Induced/genetics , Neoplasms, Radiation-Induced/immunology , Niacin/administration & dosage , Skin/drug effects , Skin/metabolism , Skin/radiation effects , Skin Neoplasms/genetics , Skin Neoplasms/immunology , Specific Pathogen-Free Organisms , Ultraviolet Rays/adverse effects
10.
Mol Cell Biochem ; 193(1-2): 69-74, 1999 Mar.
Article in English | MEDLINE | ID: mdl-10331640

ABSTRACT

Studies presented here show that cellular NAD, which we hypothesize to be the relevant biomarker of niacin status, is significantly lower in humans than in the commonly studied animal models of carcinogenesis. We show that nicotinamide and the resulting cellular NAD concentration modulate expression of the tumor suppressor protein, p53, in human breast, skin, and lung cells. Studies to determine the optimal NAD concentrations for responding to DNA damage in breast epithelial cells reveal that DNA damage appears to stimulate NAD biosynthesis and that recovery from DNA damage occurs several hours earlier in the presence of higher NAD or in cells undergoing active NAD biosynthesis. Finally, analyses of normal human skin tissue from individuals diagnosed with actinic keratoses or squamous cell carcinomas show that NAD content of the skin is inversely correlated with the malignant phenotype. Since NAD is important in modulating ADP-ribose polymer metabolism, cyclic ADP-ribose synthesis, and stress response proteins, such as p53, following DNA damage, understanding how NAD metabolism is regulated in the human has important implications in developing both prevention and treatment strategies in carcinogenesis.


Subject(s)
NAD/metabolism , NAD/physiology , Neoplasms/prevention & control , Neoplasms/therapy , Animals , Breast Neoplasms/metabolism , Humans , Lung Neoplasms/metabolism , Niacin/blood , Niacin/metabolism , Rats , Skin/metabolism , Skin Neoplasms/metabolism , Species Specificity , Time Factors , Tissue Distribution , Tumor Cells, Cultured , Tumor Suppressor Protein p53/metabolism
11.
Mol Cell Biochem ; 193(1-2): 75-81, 1999 Mar.
Article in English | MEDLINE | ID: mdl-10331641

ABSTRACT

We have recently described the isolation and characterization of bovine cDNA encoding poly(ADP-ribose) glycohydrolase (PARG). We describe here the preparation and characterization of antibodies to PARG. These antibodies have been used to demonstrate the presence of multiple forms of PARG in tissue and cell extracts from bovine, rat, mouse, and insects. Our results indicate that multiple forms of PARG previously reported could result from a single gene. Analysis of PARG in cells in which poly(ADP-ribose) polymerase (PARP) has been genetically inactivated indicates that the cellular content of PARG is regulated independently of PARP.


Subject(s)
Gene Expression Regulation, Enzymologic , Glycoside Hydrolases/genetics , Glycoside Hydrolases/metabolism , Animals , Cattle , Cell Line , Cloning, Molecular , Genotype , Glycoside Hydrolases/immunology , Mice , Models, Biological , Models, Genetic , Rats , Recombinant Fusion Proteins , Tumor Cells, Cultured
12.
AIDS Read ; 9(8): 563-72, 1999 Nov.
Article in English | MEDLINE | ID: mdl-11082734

ABSTRACT

HIV replication can now be effectively suppressed using antiretroviral combination regimens. The search continues, however, for ways to restore the immune response and eliminate reservoirs of latent infection. Interleukin-2 (IL-2) may augment the immune response in HIV-infected persons. This article discusses the rationale for using IL-2 in those with HIV disease and reviews key trials of IL-2 treatment regimens.


Subject(s)
HIV Infections/immunology , Immune System/drug effects , Interleukin-2/therapeutic use , Antiretroviral Therapy, Highly Active , CD4 Lymphocyte Count , Dose-Response Relationship, Drug , HIV Infections/drug therapy , Humans , Immunity/drug effects , Immunotherapy , Interleukin-2/administration & dosage , Interleukin-2/pharmacology , Killer Cells, Natural/drug effects , Killer Cells, Natural/immunology , Receptors, Interleukin-2/drug effects , Receptors, Interleukin-2/immunology , Virus Latency/drug effects , Virus Latency/immunology
13.
J Biol Chem ; 273(46): 30069-72, 1998 Nov 13.
Article in English | MEDLINE | ID: mdl-9804757

ABSTRACT

Poly(ADP-ribose) polymerase (PARP) (EC 2.4.2.30), the only enzyme known to synthesize ADP-ribose polymers from NAD+, is activated in response to DNA strand breaks and functions in the maintenance of genomic integrity. Mice homozygous for a disrupted gene encoding PARP are viable but have severe sensitivity to gamma-radiation and alkylating agents. We demonstrate here that both 3T3 and primary embryo cells derived from PARP-/- mice synthesized ADP-ribose polymers following treatment with the DNA-damaging agent, N-methyl-N'-nitro-N-nitrosoguanidine, despite the fact that no PARP protein was detected in these cells. ADP-ribose polymers isolated from PARP-/- cells were indistinguishable from that of PARP+/+ cells by several criteria. First, they bound to a boronate resin selective for ADP-ribose polymers. Second, treatment of polymers with snake venom phosphodiesterase and alkaline phosphatase yielded ribosyladenosine, a nucleoside diagnostic for the unique ribosyl-ribosyl linkages of ADP-ribose polymers. Third, they were digested by treatment with recombinant poly(ADP-ribose) glycohydrolase, an enzyme highly specific for ADP-ribose polymers. Collectively, these data demonstrate that ADP-ribose polymers are formed in PARP-/- cells in a DNA damage-dependent manner. Because the PARP gene has been disrupted, these results suggest the presence of a previously unreported activity capable of synthesizing ADP-ribose polymers in PARP-/- cells.


Subject(s)
Poly Adenosine Diphosphate Ribose/biosynthesis , Poly(ADP-ribose) Polymerases/physiology , 3T3 Cells/drug effects , 3T3 Cells/metabolism , Animals , Chromatography, High Pressure Liquid , Genotype , Methylnitronitrosoguanidine/pharmacology , Mice , Mice, Inbred C57BL , Mice, Knockout , Mutagens/pharmacology , NAD/metabolism , Poly(ADP-ribose) Polymerases/genetics
14.
J Biol Chem ; 272(18): 11895-901, 1997 May 02.
Article in English | MEDLINE | ID: mdl-9115250

ABSTRACT

The synthesis and rapid turnover of ADP-ribose polymers is an immediate cellular response to DNA damage. We report here the isolation and characterization of cDNA encoding poly(ADP-ribose) glycohydrolase (PARG), the enzyme responsible for polymer turnover. PARG was isolated from bovine thymus, yielding a protein of approximately 59 kDa. Based on the sequence of oligopeptides derived from the enzyme, polymerase chain reaction products and partial cDNA clones were isolated and used to construct a putative full-length cDNA. The cDNA of approximately 4.1 kilobase pairs predicted expression of a protein of approximately 111 kDa, nearly twice the size of the isolated protein. A single transcript of approximately 4. 3 kilobase pairs was detected in bovine kidney poly(A)+ RNA, consistent with expression of a protein of 111 kDa. Expression of the cDNA in Escherichia coli resulted in an enzymatically active protein of 111 kDa and an active fragment of 59 kDa. Analysis of restriction endonuclease fragments from bovine DNA by Southern hybridization indicated that PARG is encoded by a single copy gene. Taken together, the results indicate that previous reports of multiple PARGs can be explained by proteolysis of an 111-kDa enzyme. The deduced amino acid sequence of the bovine PARG shares little or no homology with other known proteins. However, it contains a putative bipartite nuclear location signal as would be predicted for a nuclear protein. The availability of cDNA clones for PARG should facilitate structure-function studies of the enzyme and its involvement in cellular responses to genomic damage.


Subject(s)
Glycoside Hydrolases/metabolism , Thymus Gland/enzymology , Amino Acid Sequence , Animals , Base Sequence , Binding Sites , Cattle , Cloning, Molecular , DNA/chemistry , DNA/metabolism , DNA, Complementary , Escherichia coli , Genes , Glycoside Hydrolases/chemistry , Glycoside Hydrolases/isolation & purification , Humans , Kidney/enzymology , Molecular Sequence Data , Molecular Weight , Open Reading Frames , RNA, Messenger/isolation & purification , RNA, Messenger/metabolism , Recombinant Proteins/chemistry , Recombinant Proteins/isolation & purification , Recombinant Proteins/metabolism , Restriction Mapping , Sequence Homology, Amino Acid , Transcription, Genetic
16.
Adv Exp Med Biol ; 419: 371-9, 1997.
Article in English | MEDLINE | ID: mdl-9193679

ABSTRACT

Glycation is initiated by reaction of a reducing sugar with a protein amino group to generate a Schiff base adduct. Following an Amadori rearrangement to form a ketoamine adduct, a complex chemistry involving oxidation often leads to protein glycoxidation products referred to as advanced glycosylation end products (AGE). The AGE include protein carboxymethyllysine (CML) residues and a heterogeneous group of complex modifications characterized by high fluorescence and protein-protein cross links. The sugar sources for the glycoxidation of intracellular proteins are not well defined but pentoses have been implicated because they are efficient precursors for the formation of the fluorescent AGE, pentosidine. ADP-ribose, generated from NAD by ADP-ribose transfer reactions, is a likely intracellular source of a reducing pentose moiety. Incubation of ADP-ribose with histones results in the formation of ketoamine glycation conjugates and also leads to the rapid formation of protein CML residues, histone H1 dimers, and highly fluorescent products with properties similar to the AGE. ADP-ribose is much more efficient than other possible pentose donors for glycation and glycoxidation of protein amino groups. Recently developed methods that differentiate nonenzymic modifications of proteins by ADP-ribose from enzymic modifications now allow investigations to establish whether some protein modifications by monomers of ADP-ribose in vivo represent glycation and glycoxidation.


Subject(s)
Adenosine Diphosphate Ribose/metabolism , Arginine/metabolism , Fluorescence , Glycation End Products, Advanced/metabolism , Glycosylation , Hexosamines/metabolism , Histones/metabolism , Humans , Ketoses/metabolism , Lysine/metabolism , Oxidation-Reduction
17.
Adv Exp Med Biol ; 419: 381-8, 1997.
Article in English | MEDLINE | ID: mdl-9193680

ABSTRACT

Intramolecular ADP-ribose transfer reactions result in the formation of cyclic ADP-ribose (cADPR) and 2'-phospho-cyclic ADP-ribose (P-cADPR) from NAD and NADP, respectively. The potent Ca2+ releasing activity of these cyclic nucleotides has led to the postulation that they function as second messengers of Ca2+ signalling. The synthesis and hydrolysis of cADPR and P-cADPR are catalyzed by NAD(P) glycohydrolases, but the metabolic signals that regulate their metabolism are poorly understood. To investigate the physiological roles of cADPR and P-cADPR, it is essential to have methods that allow the routine measurement of these nucleotides in cellular systems. As described here, a sensitive and selective radioimmunoassay (RIA) for cADPR has been adapted to search for the natural occurrence of P-cADPR in mammalian tissues. Perchloric acid extracts prepared from bovine tissues and purified by anion exchange chromatography were found to contain immunoreactive material which was identified as P-cADPR. P-cADPR may play an important role in oxidative stress as a link between NADP(H) metabolism and alteration of intracellular Ca2+ homeostasis.


Subject(s)
Adenosine Diphosphate Ribose/analogs & derivatives , Calcium/metabolism , Oxidative Stress , Signal Transduction , Adenosine Diphosphate Ribose/chemistry , Adenosine Diphosphate Ribose/metabolism , Animals , Cattle , Cyclic ADP-Ribose , NAD/metabolism , NADP/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...